48
Participants
Start Date
October 1, 2019
Primary Completion Date
September 15, 2021
Study Completion Date
October 1, 2022
Corifollitoropin alfa (CFA)-double pick up
In the study group, 225 IU of recombinant FSH (rFSH) will continue after the first oocyte retrieval (OR). Antagonist administration will be initiated when at least one follicle measuring ≥14 mm will be present in the ultrasound. If one or more follicles ≥17 mm are observed, patients will undergo a second triggering with human chorionic gonadotropin (hCG) 5000 IU and a second OR will be performed. In case of patients with no follicular development following 10 additional days of rFSH post-OR
UZ Brussel, Brussels
CRG UZ Brussel
OTHER